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Objectives. Distance from residence location to a centre for renal replacement therapy (RRT) may influence
patients’ quality of life and prognosis. Northern Norway constitutes 45% of Norway’s landmass, but has less
than 10% of the population.
Methods. In this study, we analysed all patients in northern Norway consecutively registered in the Norwegian
Renal Registry during 20002012. A total of 634 patients (Nordland County 321 patients, Troms County 215
patients and Finnmark County 98 patients) were investigated.
Results. There were more smokers (31% vs. 22%) and patients with diabetes (32% vs. 22%) in Finnmark, but
the difference did not reach statistical significance. Patients undergoing RRT and living in Finnmark County
had a significantly worse outcome (P0.03). The median survivals after initiation of RRT were 3.8 years
(Finnmark), 6.4 years (Troms) and 5.4 years (Nordland), respectively. The most common causes of death were
cardiovascular disease (53%), infections (16%), withdrawal from therapy (15%) and malignancy (13%). In a
Cox analysis, age (PB0.0001), diabetes (P0.008) and smoking at any time (PB0.004) were individual
factors correlated with inferior prognosis.
Conclusion. Age, smoking and diabetes were prognostic factors. Residents of the northernmost county
(Finnmark) experienced an inferior prognosis. Long distance from residence location to hospital may be
another factor, but this could not be documented. Preventive strategies should be improved.
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D
istance from residence location to a centre for
renal replacement therapy (RRT) may influence
patients’ quality of life and prognosis (13).
Northern Norway covers almost half of Norway’s land-
mass, but has only 9.4% of the total population of
5.1 million inhabitants. The region has a subarctic and
arctic climate that may cause several challenges, espe-
cially during wintertime with cold weather conditions,
seasonable darkness and lot of snow. These geographical
and demographical challenges must be compensated for
to achieve a high-quality RRT health care within reason-
able costs and acceptable logistic solutions. In the most
northern county of Norway (Finnmark), the population
is scattered within a landmass (48,616 km2) 12.9% greater
than Denmark. In this region, satellite dialysis units
manned with specialised nurses have been linked to the
university clinic in Tromsø and ambulatory nephrologists
and telemedicine services have been cornerstones in the
health care service to RRT patients and their relatives (4).
Recently, nephrologists have expressed concerns about
the survival of patients undergoing RRT and living dis-
tantly from the main dialysis centre (13). Long distance
has been associated with increased risk of Staphylococcus
aureus peritonitis among patients undergoing peritoneal
dialysis (PD) (1). Samuel and co-workers documented
an association between residence location and likelihood
of transplantation among paediatric dialysis patients
(2). Similarly, Axelrod and associates (3) observed that
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patients living farther from the transplant centre and
having lower socioeconomic status had inferior kidney
transplantation access and outcomes.
The aim of this investigation was to analyse the
treatment outcome of RRT patients in northern Norway.
Methods
The Norwegian Renal Registry (NRR) was formally con-
stituted in 1994 in collaboration between the Norwegian
Renal Association (NRA) and Oslo University Hospital,
Rikshospitalet, with the latter as the formal owner (5). All
patients initiating chronic RRT in Norway are included in
the registry.
In this study, we focused on the survival of patients on
RTT in northern Norway. This northern region consists of
3 counties (Nordland, Troms and Finnmark); the popula-
tion in each county is respectively 240,000, 160,000 and
75,000 inhabitants. The location is visualized in Fig. 1. The
region has 2 major centres for RRT located at the Uni-
versity Hospital of North Norway (UNN) in Tromsø and
the Nordland Hospital situated in Bodø.
All patients included in the NRR and who had initiated
RRT between 1 January 2000 and 31 December 2012 were
included in the study. A total of 634 patients (Finnmark 
98 patients, Troms  215 patients and Nordland  321
patients) were identified. Details are shown in Table I.
Treatment withdrawal was defined as patients’ and
doctors’ decision of withdrawal from therapy.
Statistics and authorization
The comparison between the 3 counties of northern
Norway was done using t-test and chi-square statistics.
Survival was estimated employing the Kaplan Meier
method and differences between counties in northern
Norway were tested with the log-rank test. The time of
observation was from start of RRT until death, recovery,
emigration or censoring date 1 April 2013. The effects of
residency on survival were explored employing the Cox
regression analysis. Significance was set to 5% and the tests
were carried out 2-sided. Statistical Package for Social
Science (SPSS) version 16.0 was used for the database and
statistical calculations.
All patients included in the NRR have provided written
consent. In the present investigation, except for the
colleagues employed at the NRR, co-workers had only
access to anonymous and aggregated data. Consequently,
no approval from the Regional Committees for Medical
and Health Research Ethics (REK) was necessary.
Results
There was no difference in mean age at initiation of RRT
between counties in northern Norway. The incidence
rate per million population (PMP) per year was 103.6
(Finnmark), 107.4 (Troms) and 104.6 (Nordland), respec-
tively. Most patients were males (448 patients  70.7%).
The proportion of males, diabetics and smokers was the
highest in Finnmark, but differences did not reach
statistical significance. Details are shown in Table I. Only
21% of patients started with continuous ambulatory
peritoneal dialysis (CAPD) or other forms of PD, and
there were no differences between counties.
The median survivals after start of RRT were 3.8 years
(Finnmark), 6.4 years (Troms) and 5.4 years (Nordland),
respectively. Details are shown in Fig. 2. The most com-
mon causes of death were cardiovascular disease (CVD)
(53%), infections (16%), withdrawal from therapy (15%)
and malignancy (13%). Details are shown in Table II.
A significant difference in overall survival was observed
between Finnmark and Troms (P0.006) and Finnmark
and Nordland (P0.04). There was no difference between
Troms and Nordland (P0.26). In gender-specific ana-
lyses (comparing Troms and Finnmark), the significant
inferior survival rate in Finnmark was only observed
among males (P0.002).
To further clarify the findings in Finnmark and Troms,
we performed a Cox analysis. The analysis revealed age
(PB0.0001), diabetes as primary disease (P0.0082) and
smoking at any time (P0.0041) to be associated with
inferior survival. The variable ‘‘active smoker’’ did not
reach statistical significance. Smoking and diabetes
combined outweighed county (Finnmark) as risk factor.
Details are shown in Table III.
Discussion
In this study, we have documented that patients under-
going RRT in our northernmost county (Finnmark) had
a higher frequency of diabetes and smoking, and they
experienced a significantly shorter life expectancy than
patients from other counties of northern Norway.
Fig. 1. The figure shows the Scandinavian Peninsula with
Norway in grey and the 3 northern counties of Norway marked
with their names.
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Strength and limitations
The strength of this study is that it included the total
cohort of patients treated with RRT in northern Norway
during the study period. Consequently, the prognosis of
the total cohort is described. There are however limita-
tions. The data on smoking at any time should be handled
with some caution as there may be a potential bias related
to missing information on smoking in 101 patients. It may
also be discussed whether it is inappropriate to censor
data in case of recovery. Data on uncensored mortality is
discussed next.
The survival figures
Differences in mortality in the general population may
contribute to differences in mortality on RRT. It is well
known that the people of Finnmark have the lowest life
expectancy in Norway. The total mortality rate in the
age group 074 years per 100,000 in Nordland, Troms
and Finnmark was 291.1, 293.9 and 350.6, respectively,
during 20022011 (www.helse-nord.no/helseatlasnord).
It could be claimed that a centre with high recovery
rates will have an apparent poorer RRT survival simply
due to shorter mortality-free exposure-time. In our study,
the recovery figures of Troms, Finnmark and Nordland
were 1% (2/213), 5.5% (5/93) and 5% (16/305), respectively.
As we implemented data directly from the Norwegian
Population Registry on all patients who have been in-
cluded in the NRR, we could access data on uncensored
mortality. Whereas the 1-year survival figures were 80.4%
(Finnmark), 87.3% (Troms) and 83.1% (Nordland), the
corresponding 5-year figures were 34.6, 50.2 and 47.7%,
respectively. Comparing Finnmark and Troms counties,
the difference was still statistically significant (P0.0254).
The difference between Finnmark and Nordland did not
reach statistical significance (P0.0622).
Compared to other studies
Van Dijk et al. (6) revealed that only 26% of the European
northsouth mortality difference in RRT could be attrib-
uted to differences in general population mortality. It
could be speculated that there is a northsouth gradient
within northern Norway. Such a gradient has been
observed within Europe with a 35% lower mortality rate
among patients on RRT in the south of Europe (6). The
crude annual death rate of patients on RRT ranged from
200 per 1,000 patient years (py) in Northern Europe to 132
per 1,000 py in Southern Europe. The mortality on RRT
was highest in Sweden (239 per 1,000 py) and lowest in
Basque country (118 per 1,000 py). We have not revealed
any explanation for this finding. However, when looking at
our figures, it is only Finnmark County that deviates from
the national figures. Troms County had, during the study
period, the fifth best survival figure in Norway (personal
communication Torbjørn Leivestad).
Table I. Demographics, age, gender, smoking and diabetes among RTT patients in northern Norway according to county of residence
at the time of initiation of therapy
Variables Finnmark Troms Nordland
Patients (numbers) 98 215 321
Incidence rate (PMP/year) 103.6 107.4 104.6
Median age (years) [range] 65.7 (0.0483.5) 64.8 (15.190.5) 67.7 (1.388.9)
Males (%) 75 (76.5) 150 (69.8) 223 (69.5)
Diabetes
Diabetic nephropathy (%) total 85 patients 20 (20.4) 26 (12.1) 39 (12.1)
Diabetes total (%) total 150 patients 31 (31.6) 46 (21.4) 73 (22.7)
Smokinga
Never smokeda (%) 20 (26.0) 68 (37.4) 109 (39.8)
Active smokera (%) 24 (31.2) 39 (21.4) 61 (22.3)
None of the differences reached statistical difference. PMPper million population.
aSmoking habits were only available for patients treated between 2005 and 2012. In total, 101 patients were excluded due to lack of data
on smoking habits.
Fig. 2. The figure shows the survival curves (Kaplan Meier
method) of patients undergoing renal replacement therapy
according to county of residence in northern Norway.
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We revealed CVD, malignancy and infection as the most
common causes of death among patients with end-stage
kidney disease in northern Norway. This is in accordance
with findings by other authors (79). Especially following
kidney graft failure, infection has been reported the most
common cause of death (7,8). Looking at our absolute
figures, Nordland County had the lowest figure of deaths
caused by infections (12%). Prior analyses have shown that
the Nordland Hospital in general has low prevalence
figures with regard to rate of hospital infections (10). In
the future, retrospective analysis of electronic patient
records (EPR) employing specific tools, for example the
Global Trigger Tool (GTT), could be performed to clarify
the kind and percentage of infections that can be avoided/
prevented.
Among RRT patients, Finnmark County had the
highest death rate due to fatal infections. Long distance
has been associated with increased risk of fatal infections
(1). We had no data on the bacteria or virus that caused
fatal infections or the time from early symptoms to
treatment. We are well aware of Finnmark by far being
the largest county in Norway and its network of air
ambulance resources available in the region. These re-
sources may compensate for long distances and transport
of patients and health care workers in emergency situa-
tions (10). The slightly lower risk of dying from cancer
among RRT patients in Finnmark must be seen in the
context of the short life expectancy observed among RRT
patients. It takes time to develop cancer. The higher share
of males in Finnmark may also have had an effect on the
figures as males usually get cancer in older age than
females do.
For decades, the association between tobacco smoking
and lung and CVDs has been well known. Sánchez-
Perales et al. (11) recorded acute myocardial infarction
(AMI) among the patients treated in their dialysis unit in
Spain between 1999 and 2007. The factors that predicted
the occurrence of AMI in dialysis were older age,
previous coronary artery disease and diabetes as a cause
of nephropathy. Post-infarction mortality was very high
and multi-vessel disease was very frequent.
The population of Finnmark lives in the northern
subarctic area and frequently experiences the roughest
weather conditions on the Norwegian mainland. They
have 2 months with seasonable darkness and long-lasting
winters. Cold weather increases the risk of CVD (12).
Exposure to cold air causes a rise in blood pressure and
haemoconcentration, which leads to increased tendency
for vascular thrombosis (12,13). Added to the high per-
centage of smokers among RRT patients in Finnmark, it
may look surprising that CVD was not a more common
cause of death in this county.
The inferior prognosis among RRT patients in Finn-
mark was only observed among males. Different survival
Table II. The table shows mode of treatment, deaths and cause of death according to patients’ county of residence in northern Norway
Finnmark Troms Nordland
Variables No (%) No (%) No (%)
Patients 98 (100) 215 (100) 321 (100)
Started with PD 20 (20.4) 47 (21.9) 67 (20.9)
Predialytic transplantation 10 (10.2) 22 (10.2) 19 (5.9)
Achieved transplantation 35 (35.7) 100 (46.5) 124 (38.6)
Death (by May 2013) 55 (56) 91 (42) 156 (49)
Cause of death: number (% of deaths)
Withdrawn from RRT 8 (15) 16 (17) 20 (13)
Cardiovascular disease 25 (45) 48 (53) 86 (55)
Infections 12 (22) 16 (18) 19 (12)
Malignancy 6 (11) 10 (11) 22 (14)
Other causes 4 (7) 1 (1) 9 (6)
PDperitoneal dialysis; RRTrenal replacement therapy.
Table III. The table shows the covariates analyzed and Hazard ratio
Covariate Hazard ratio Hazard 95% CI p
County (Finnmark vs. Troms) 1.596 0.9222.208 0.1106
Age at start of RRT (by year) 1.104 1.071.129 B0.0001
Male sex 1.344 0.8512.122 0.2045
Diabetes primary disease 2.221 1.2304.011 0.0082
Smoking at any time 1.930 1.2323.025 0.0041
Age, diabetes and smoking were associated with inferior patient survival. RRTrenal replacement therapy.
Jan Norum et al.
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figures have been documented between genders (1416).
A few years ago, Eriksen and Ingebretsen (14) documen-
ted female gender associated with slower decline in GFR
and better patient and renal survival. Furthermore, they
concluded that the effect of gender on the progression
of chronic kidney disease had been a matter of debate,
where most of the evidence seemed to point towards a
negative effect of male gender.
Studies have shown inferior survival among patients
undergoing RRT and living distantly from the main
dialysis centre (13). Samuel and co-workers documented
an association between residence location and likelihood
of transplantation among paediatric dialysis patients (2).
Similarly, Axelrod and associates (3) observed patients
living farther from the transplant centre and having lower
socioeconomic status had inferior kidney transplantation
access and outcomes. Compared to northern Norway and
Norway in general, the people of Finnmark (both gender)
have a shorter life expectancy (www.ssb.no). In our survey,
the transplantation rate was highest in the university hos-
pital region (Troms) and lowest in Finnmark. The care of
patients undergoing RRT in Finnmark was administered
and run by nephrologists at the UNN. The same practice
with regard to transplantation and follow-up were em-
ployed in Finnmark as in Troms County. Differences
in transplantation rate were due to different patient
characteristics.
Conclusion
In this study, we have documented that patients under-
going RRT in the most northern county (Finnmark) had
the highest frequency of diabetes and smoking, and males
experienced a significantly shorter life expectancy. Despite
the fact that the higher frequency of diabetes and smoking
did not reach statistical significance in Finnmark, these
factors were documented individual prognostic factors.
We therefore encourage smoking cessation strategies/
campaigns and efforts to improve the treatment of
diabetes. The latter may be improved by more frequent
use of the NOKLUS Diabetes software (17) available in
northern Norway’s hospitals. This software provides
decision support and data collection/overview and an
almost complete diabetes medical record.
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